| 1/1 | US=65 / Biol/Mol Gill JH, Loadman PM. Development of tumour-selective and endoprotease-activated anticancer therapeutics. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 853-76. ISBN 978-0-387-69056-8. DESENVOLVIMENTO DE TUMORES SELETIVOS; ENDOPROTEASE ATIVADO; TERAPEUTICA ANTICANCER |